To investigate the specific contribution of select MHC class II genes on the development of murine lupus, H-2 congenic (NZB x BXSB)F1 hybrid mice bearing either H-2b/b, H-2d/b or H-2d/d haplotypes were generated. We compared the clinical development (autoantibody production and glomerulonephritis) of systemic lupus erythematosus (SLE) 
Introduction
There exists ample evidence suggesting that many genetic factors play an essential role in the pathogenesis of systemic lupus erythematosus (SLE).' Early genetic studies in New Zealand mice have demonstrated that multiple, unlinked genes are responsible for the production of a variety of autoantibodies and the expression of various disease manifestations (1) (2) (3) (4) (5) . However, the nature of the genes implicated in SLE is still unclear.
Since the genes encoding for MHC molecules participate in 1 . Abbreviations used in this paper: B6, C57BL/6; gp7O IC, gp7O-antigp7O immune complexes; SLE, systemic lupus erythematosus; Yaa, Y chromosome-linked autoimmune acceleration.
both the regulation of the immune response and the selection of T cell specificities from the repertoire, it has been postulated that MHC class II genes are primary candidates to determine susceptibility for the development of SLE. In fact, an association of particular MHC class II haplotypes with SLE has been previously reported in patients with SLE (6) . Studies on H-2 congenic (NZB x NZW)Fj and (NZW x BXSB)Fl hybrid mice and on F2 offspring of NZB x SWR crosses have suggested that unique hybrid MHC class H molecules produced in these F1 hybrid mice may act as restriction elements for their autoimmune disease (7) (8) (9) . More recently, it has been proposed that a mixed haplotype molecule, I-EadE/3z, may be responsible for the predisposition to the SLE in (NZB X NZW)Fj hybrid mice (10) . Other evidence that supports the role of MHC class II molecules in the regulation of murine SLE is that the introduction of the bml2 mutation in the I-A/3 chain in NZB mice results in a dramatic increase of autoantibody production and the rapid development of severe lupus nephritis (11, 12 Serological assays. Serum levels of IgG anti-DNA autoantibodies were determined by ELISA, and results are expressed in titration units, as described previously (17) . Serum levels of gp70-anti-gp70 immune complexes (gp7O IC) were quantified by an ELISA combined with the precipitation of the serum with polyethylene glycol (average molecular weight 6,000), and results are expressed as yg/ml of gp70 complexed with anti-gp70 antibodies, as described previously (15) .
Histopathology. Samples of all major organs were obtained at autopsy, and histological sections stained either with the periodic acidSchiff reagent or with hematoxylin eosin. Glomerulonephritis was scored on 0 to 4 scale, in blind, based on the intensity and extent of histopathological changes, as described previously (2), according to . Grades 3 and 4 glomerulonephritis were considered significant contributors to clinical disease and/or death.
cDNA cloning and sequencing. Total cellular RNA from spleens of BXSB (H-2") mice were extracted using the guanidine isothiocynateCsCI method ( 19) . First strand of cDNA was synthesized with a mixture of an oligo(dT) and 3' primers, and 5 Isg of total RNA (20) . For amplification with Taq DNA polymerase (Perkin-Elmer Corp., Norwalk, CT), the following primers (5 '-3') were used: 5' primer (5 '-CAGCAT-GCTCAGCCTCTGTGGA-3') and 3' primer (5 '-TCGTCGACTGAC-TTGCTATTTCTGAG-3') for the I-Aa chain, and 5' primer (5'-GGCTGCAGTGGTGGTGCTGATGGTG-3') and 3' primer (5'-TGTCTAGAAATCTGTCACTGAGCAGA-3') for the I-A3 chain. Polymerase chain reaction (PCR) was performed following the recommendations of the manufacturer (Perkin-Elmer Corp.). The amplified fragments were purified on 5% polyacrylamide gel and inserted into pBluescript [I SK or pUC1 18 vector. The nucleotide sequences corresponding to the acr and P 1 domains of the I-Aa and I-AB chains were determined by dideoxynucleotide chain termination method (21) using M13 primers. Predicted amino acid sequences were derived from nucleotide consensus sequences of independent clones for each a and ,B1 domain.
Statistical analysis. Survival curves were estimated with BMDP Statistical Software (22) and compared using the Breslow statistic (23). Statistical analysis for serological parameters was performed with the Wilcoxon two-sample test. Probability values > 5% were considered insignificant.
Results
MHC association of SLE in (NZB X BXSB)F, females. To study the contribution of MHC class II genes on the development of SLE, (NZB x BXSB)Fl hybrids bearing different H-2 haplotypes (H-2b'b, H-2d/b, or H-2d d) were generated, and the development of murine lupus was analyzed in female mice lacking the Yaa gene. (NZB x BXSB)F, females of both H2b'b and H-2d/b haplotypes developed typical lupus in the first year of life; 50% of them died of glomerulonephritis by 7 and 9 mos, and only 10% were alive at 10 and 11 mos, respectively ( Fig. 1 A) . In contrast, the development of a lupus-like syndrome in H-2d'd female hybrid mice was markedly delayed; their 50% cumulative mortality rate was at 15 mo of age.
The spontaneous production of IgG anti-DNA autoantibodies and gp7O IC was examined in these three F, hybrid females. Serum levels of IgG anti-DNA autoantibodies increased with age; by 6 mo of age, the majority of H-2b/b and H-2dlb (NZB x BXSB)Fj female hybrid mice demonstrated significant anti-DNA antibody activities at comparable titers ( Fig. 1 B and Table I ). In addition, both groups of female mice had essentially identical amounts of gp7O IC at 4 mo of age ( Fig. 1 C (Fig. 2 A) .
In correlation with their mortality rates, these three hybrid males bearing the Yaa gene had comparable levels of IgG anti-DNA autoantibodies and gp7O IC in sera at 4 mo of age (Fig.   2 , B and C; Table I (Table I) (28) . Although the protective effect conferred by the Ead transgene has not been totally elucidated, our recent studies on different lupus-prone mice have shown that the protective effect of an Ead transgene varies in lupus-prone mice, depending on the severity of the disease developing in mice studied (Iwamoto, M., N. Ibnou-Zekri, R. Merino, M. E. Gershwin, and S. Izui, manuscript in preparation). Thus, it may not be surprising to see that the inhibitory effect by the I-E molecules on autoimmune responses can be much greater in B6-lpr/lpr mice than in lupusprone (NZB x BXSB)F, mice, which develop more severe SLE than B6-lpr/lpr mice (13, 16) . It is striking that the Yaa gene completely abolishes the MHC effect on the development of SLE occurring in (NZB x BXSB )F, female mice; this resulted from a remarkable accelerating effect mediated by the Yaa gene in H-2d/d males, as compared with its limited effect on H-2b"b and H-2d'b males.
These data are consistent with the thesis that the capacity of the Yaa gene to promote autoimmune responses depends on the levels of autoantibodies spontaneously produced in different lupus-prone mice ( 15, (29) (30) (31) (32) (33) (34) (32, 33) . In contrast, in (NZB X BXSB)F, hybrid mice, the presence of NZB and BXSB genomes and their genetic complementation apparently allow the development of a limited, but significant autoimmune responses, even in the context of the H-2d; thus, the Yaa gene is able to accelerate the progression of their SLE.
Our results indicate that the conventional H-2b is a more susceptible haplotype for SLE than the H-2d, while such a MHC effect can be completely masked by the presence of accelerating factors, such as the Yaa gene. The precise role of the MHC class II molecules and the Yaa gene in the development of SLE remains to be determined. Considering the central role of the MHC molecules in the generation of the T cell repertoire, we favor the hypothesis that the MHC control is likely to be a consequence of thymic selection by the predisposing MHC haplotype of a harmful autoreactive T cell repertoire. It is possible that an autoimmune genetic background or the Yaa gene may be implicated in this selection process. As shown in recent studies on two different models of transgenic mice (35, 36) , autoreactive T cells specific to minor determinants of autoantigens can be positively selected and evade tolerance induction even in non-autoimmune mice. However, they cannot be optimally stimulated in non-autoimmune mice, because the avidity of these T cell receptors to self peptide-MHC complexes may not be high enough to be activated. An attractive hypothesis is that the action of the Yaa gene may be to help promote the lowavidity interaction and subsequent activation of autoreactive T and B cells, possibly through T cell recognition of a Yaa-related molecule expressed on B cells, as we have recently proposed (37, 38 
